AudioAbstracts
AudioAbstracts by ReachMD provides an easy-to-digest distillation of important medical literature in combination with digital linkage to in-depth information supporting the audio synopsis. AudioAbstracts harnesses the ReachMD digital network to broadcast the spoken synopsis and related digital links through its on-air, online, onsite, and mobile distribution network. Combining quick-read audio synopses with links to source material, AudioAbstracts is the smarter, faster way to stay current on medical literature.
Episodes 1-15 of 43
Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Project Oncology®Evaluating a Lower-Intensity Treatment Regimen in AML: Phase 2 Results from PARADIGM
Screening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Clinician's RoundtableScreening for Prediabetes in Youth with Obesity: Evaluating the TyG Index
Targeting Head and Neck Atopic Dermatitis: Long-Term Outcomes with Tralokinumab
DermConsultTargeting Head and Neck Atopic Dermatitis: Long-Term Outcomes with Tralokinumab
Adverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Living RheumAdverse Childhood Experiences in cSLE: A Clinically Significant but Underrecognized Burden
Improved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Clinician's RoundtableImproved Pathogen ID in Sepsis with Clinical Metagenomic Sequencing
Saliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
Clinician's RoundtableSaliva as a Window Into Cystic Fibrosis: Metabolic Biomarkers and Clinical Potential
- advertisement
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Eye on Ocular HealthOCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Triglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Heart MattersTriglycerides and Residual Risk in Secondary Cardiovascular Prevention: Lessons From UCC-SMART
Decoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
NeuroFrontiersDecoding Disability Worsening in MS: The Case for Combining CSF and Serum Biomarkers
Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Project Oncology®Predicting Hydroxyurea Resistance in Polycythemia Vera with Machine Learning
Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Project Oncology®Beyond Disease Control: PROs With Odronextamab in R/R Follicular Lymphoma
Diagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
Living RheumDiagnosing Long COVID: Rheumatologic Implications of 2024 Criteria
- advertisement
Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
Project Oncology®Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
Epithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Living RheumEpithelial Cell Activation in Sjögren’s: A New Target in Chronic Inflammation
Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
Project Oncology®Are Subcutaneous Immunotherapies Expanding Access and Efficiency in Cancer Care?
